Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet (18)    NLM QUALITY MEASURE GROUPS (802.3)

Name Value
MEASURE TITLE Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet
CMS ID CMS164v5
VERSION NUMBER 5.2.000
DEVELOPER National Committee for Quality Assurance
STEWARD National Committee for Quality Assurance
COPYRIGHT
Physician Performance Measure (Measures) and related data specifications 
of the Measures. (C) 2008-2016 National Committee for Quality Assurance. 
All Rights Reserved. Limited proprietary coding is contained in the Measure 
specifications for user convenience. Users of proprietary code sets should 
obtain all necessary licenses from the owners of the code sets. NCQA disclaims 
all liability for use or accuracy of any CPT or other codes contained in 
the specifications.CPT(R) contained in the Measure specifications is copyright 
2004-2015 American Medical Association. LOINC(R) copyright 2004-2015 Regenstrief 
Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED 
CT[R]) copyright 2004-2015 International Health Terminology Standards Development 
Organisation. ICD-10 copyright 2015 World Health Organization. All Rights 
were developed by the National Committee for Quality Assurance (NCQA). 
Reserved.
The Measures are copyrighted but can be reproduced and distributed, without 
modification, for noncommercial purposes (eg, use by healthcare providers 
in connection with their practices). Commercial use is defined as the sale, 
licensing, or distribution of the Measures for commercial gain, or incorporation 
of the Measures into a product or service that is sold, licensed or distributed 
for commercial gain. Commercial use of the Measures requires a license 
agreement between the user and NCQA. NCQA is not responsible for any use 
VALUE SETS
  • VALUE SET OID:   2.16.840.1.114222.4.11.837
    VALUE SET VERSION DATE:   2016-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1048
    VALUE SET VERSION DATE:   2016-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1016
    VALUE SET VERSION DATE:   2016-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.104.12.1003
    VALUE SET VERSION DATE:   2016-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1001
    VALUE SET VERSION DATE:   2016-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.104.12.1010
    VALUE SET VERSION DATE:   2016-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1025
    VALUE SET VERSION DATE:   2016-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1023
    VALUE SET VERSION DATE:   2016-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113762.1.4.1
    VALUE SET VERSION DATE:   2016-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.114222.4.11.3591
    VALUE SET VERSION DATE:   2016-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.114222.4.11.836
    VALUE SET VERSION DATE:   2016-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.104.12.1001
    VALUE SET VERSION DATE:   2016-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.526.3.1240
    VALUE SET VERSION DATE:   2016-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.196.12.1283
    VALUE SET VERSION DATE:   2016-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.196.12.1211
    VALUE SET VERSION DATE:   2016-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.104.12.1002
    VALUE SET VERSION DATE:   2016-04-01 00:00:00
GUID 0713ea8f-0e5b-4099-8c7c-dd677280398f
NQF NUMBER 0068
DESCRIPTION
Percentage of patients 18 years of age and older who were diagnosed with 
acute myocardial infarction (AMI), coronary artery bypass graft (CABG) 
or percutaneous coronary interventions (PCI) in the 12 months prior to 
the measurement period, or who had an active diagnosis of ischemic vascular 
disease (IVD) during the measurement period, and who had documentation 
of use of aspirin or another antiplatelet during the measurement period.
CATEGORY Individual Characteristic
IDENTIFIER 164
STATUS COMPLETED
TYPE PROCESS
MEASURE SET CY 2014 EP